biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by TechnicalBuyon Aug 20, 2011 11:54am

334 Views

Post# 18963341

RE: BTI - Important for the times ahead...

Amorak, I'm glad to see that following your DD you've decided to invest in Bioasis. I've followed your discussion on RVX for a long time and I know you are an insightful poster. Welcome aboard.The intelligence on this board is growing. Even though there are only a handful of posters on the board for now, the discussion on this board is probably the most insightful you will find on sh. This is a good sign because it means we are still in the early stages of what will hopefully become the Bioasis success story.TBtechnicalbuy.com

Bullboard Posts

Changing Europe’s dependency on HREE from China